Earningsreport

Q3/2024 9/30/2024 EPS -0.330 ZacksConsensus -0.370 ActVsEst 0.040 - Beat

CollPlant Biotechnologies Ltd. - Ordinary Shares  (CLGN) 
US:NASDAQ Investor Relations: collplant.com/investor-relation